$GALE Galena Biopharma (GALE) Overall Average: 72% Sell. Wednesday,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$GALE Overall Average: 72% Sell. $SLM $HBAN $FITB

Galena Biopharma (GALE) Buy - Hold - Sell - Overall Opinion

GALE Last Price: 3.35
Current Change: -0.17 (-4.83%)

Composite Indicators - Signal
TrendSpotter - Sell

Short Term Indicators
7 Day Average Directional Indicator - Sell
10 - 8 Day Moving Average Hilo Channel - Sell
20 Day Moving Average vs Price - Sell
20 - 50 Day MACD Oscillator - Sell
20 Day Bollinger Bands - Hold

Short Term Indicators Average: 80% Sell
20-Day Average Volume - 9,159,795



Medium Term Indicators
40 Day Commodity Channel Index - Hold
50 Day Moving Average vs Price - Sell
20 - 100 Day MACD Oscillator - Sell
50 Day Parabolic Time/Price - Sell

Medium Term Indicators Average: 75% Sell
50-Day Average Volume - 10,023,428

Long Term Indicators
60 Day Commodity Channel Index - Sell
100 Day Moving Average vs Price - Sell
50 - 100 Day MACD Oscillator- Buy

Long Term Indicators Average: 33% Sell
100-Day Average Volume - 7,328,068

Overall Average: 72% Sell

Price - Support - Pivot Point - Resistance
3.35 3.23 3.39 3.55


Last Updated: Wednesday, March 12, 2014 07:50:28 AM

GALE Stock Message Board and Forum http://investorshangout.com/search?q=GALE&...mp;yt0=Go!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Cheers to 25 Years: Go City Reintroduces Original Prices

Updated Category News Views 176

Celebrating 25 Years of The London Pass In an exciting move, Go City, a leader in the sightseeing and attraction pass industry, is commemorating the 25th anniversary of The London Pass. This initiative is a nostalgic nod to its origins, offering a limited number of passes at the original price. For travelers and locals alike, this is a fantastic opportunity to explore...

Continue Reading
Metagenomi Showcases Promising Hemophilia A Treatment Data

Updated Category News Views 276

Metagenomi Showcases Key Developments in Hemophilia A Treatment Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company, recently shared exciting updates at the American Society of Hematology (ASH) 66th Annual Meeting, highlighting their progress in the field of hemophilia A. Through their innovative gene editing toolbox, Metagenomi has demonstrated safe and...

Continue Reading
Explore Upcoming Conferences with Option Care Health Insights

Updated Category News Views 113

Upcoming Investor Conferences for Option Care Health Option Care Health, Inc. (Nasdaq: OPCH) is poised to showcase its leadership in the infusion services industry by participating in notable investor conferences. As the nation's largest independent provider of home and alternate site infusion services, the company aims to engage with investors and stakeholders through a...

Continue Reading
Bluumly Emerges as Finalist for 2025 MIT Innovation Showcase

Updated Category News Views 237

Bluumly Selected as Finalist for MIT Sloan CIO Symposium Event Innovative AI Marketing Solutions for Small Enterprises Highlighted Bluumly has proudly secured a position as one of the finalists for the prestigious Innovation Showcase at the MIT Sloan CIO Symposium. This recognition comes as the company showcases its groundbreaking AI-driven marketing solutions designed to...

Continue Reading
Transform Your Life: Discovering Resilience Against Pain

Updated Category News Views 156

Transformative Approaches to Chronic Pain Management Chronic pain is a common issue that impacts the lives of millions. In a recent exploration titled "Mastering Chronic Pain: How Peak Resilience Unlocks Your Potential," the innovative strategies introduced by NoceViva highlight the need for a holistic approach to pain management. With over 50 million Americans...

Continue Reading